Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.

University Hospital Schleswig-Holstein

Overview

The disruption of the pancreatic duct seems to be a major cause pseudocyst formation and persistence in patients suffering from acute/chronic pancreatitis. No prospective randomized studies have been conducted on the influence of pancreatic duct stenting for the patients' benefits and recurrence rates. The aim fo this study is therefore to evaluate prospectively in a randomized, controlled fashion in patients wit pancreatic pseudocysts, wether pancreatic duct stenting of a disrupted pancreatic duct is beneficial in terms of quicker clinical recovery and avoidance of recurrence of pancreatic pseudocysts.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Chronic Acute Pancreatitis

Interventions

pancreatic duct stentingPROCEDURE

in case of a disrupted pancreatic duct, patients will undergo pancreatic duct stenting.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * pancreatic pseudocyst, at least 6 cm in diameter * symptomatic pancreatic pseudocyst * increasing size of pancreatic pseudocyst within 6 weeks Exclusion Criteria: * Pregnancy * Age less than 18 years * Postoperative status preventing access to papilla * Allergy to contrast preventing from ERP * Missing informed consent to study * PTT above 1.5 times of normal, unless substituted * Platelet count less than 50.000/µl, unless substituted * Pancreatic ascites or fistula * Life expectancy less than 2 years * Percutaneously drained cysts are not part of the study

Locations (1)

Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel

Kiel, Germany

Outcomes

Primary Outcomes

Recurrence of pancreatic pseudocyst

Time frame: two years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.